Growing occurrences of respiratory diseases is one of the significant factors influencing the market growth.

The increased advancements in NGS platforms, a decrease in the price of sequencing, and improving the NGS-based diagnostic test reimbursement scenario are driving the demand for the market.

Neurostimulators are sometimes called pacemakers of the brain and are used to control specific targets in the brain to treat movement conditions such as Parkinson’s disease, dystonia, and essential tremors.

Increasing investment in R&D in molecular diagnostics, new product development, and rising prevalence of targeted diseases are some key factors driving market revenue growth.

Market development is guided mainly by the growing usage of medical imaging modalities owing to the increasing prevalence of chronic diseases, increasing concerns about sensitivity to radiation dose, progress in the installed base of radiology equipment,...

The increasing research in cancer, rising occurrence of metastatic urothelial carcinoma and presence of a strong pipeline, are expected to be some major drivers for the market.

The increased incidence of chronic illnesses and genetic disorders and increased spending by governments are driving the demand for the market.

The technical advancements, government funding, and the growing panel of Newborn diseases are driving the market.

The growth of the market is primarily driven by the growing need to curb rising healthcare costs as well as government initiatives to improve patient care and safety.